Learn More
Medchemexpress LLC 4-Hydroxymethylpyrazole | 25222-43-9 | 99.74% | 98.11 | 25 G

Supplier: Medchemexpress LLC 25GHY33914
4-Hydroxymethylpyrazole is the primary metabolite of Fomepizole, resulting from hepatic oxidative metabolism. Its plasma concentration correlates positively with the administered Fomepizole dosage, and it has a relatively short half-life. It inhibits alcohol dehydrogenase (ADH) in humans and monkeys, although its in vivo impact is considered negligible due to a significantly higher inhibition constant than Fomepizole.
- Functions as an endogenous metabolite
- Demonstrates inhibitory effects on alcohol dehydrogenase
- Suitable for research in metabolic diseases and natural products
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.